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Olav Rooyackers and Jan Wernerman*Recently, a number of clinical trials have investigated the
effect of nutrition in critical illness [1-4]. The results
have been confusing rather than clarifying. Obviously
there are difficulties in defining whether or not a specific
patient is at a nutritional risk and also what should be
the nutritional target in the early course of critical ill-
ness. The step from a nutritional intervention in the
ICU to mortality outcomes is just too big and there is
no well-known underlying mechanism. Not surprisingly,
there are no prospective randomised studies demonstrat-
ing survival advantages in relation to nutrition.
Loss of muscle mass is a cardinal symptom in patients
with need for a prolonged ICU stay. Degree of muscle
depletion has been demonstrated to relate to success of
rehabilitation efforts as well as to post-ICU quality of
life. But the actual loss of protein in muscle must be
quantified in a biopsy specimen [5-7], which makes it
very difficult to use protein content as a marker in the
individual subject in clinical practice (Figure 1). In
addition, there is no direct relation between muscle mass
and muscle function. Tests of muscle function during
critical illness are difficult because tests independent of
patient compliance are needed. Measures of muscle
turnover are often invasive and therefore are limited in
terms of repeats. Invasive measuring will still be neces-
sary to clarify underlying mechanisms, but will never be
a part of clinical practice. Imaging is therefore very at-
tractive, particularly if imaging devices can be utilised at
the bedside.
Abdominal computed tomography scans, performed
for other purposes, have been utilised in oncological pa-
tients to diagnose sarcopenia and to demonstrate the
progress of sarcopenia over time [13,14]. This concept is
now transferred to critically ill patients in the ICU
[15,16], and in a recent report Weijs and colleagues
reported a predictive value of sarcopenia during the ICU
stay [17]. In a subgroup within the Early Parenteral* Correspondence: jan.wernerman@karolinska.se
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ally Ill Patients study, computed tomography scanning of
the leg and abdomen was also used to assess the tem-
poral loss of muscle tissue [18]. Within that study the
losses of leg muscle in repeated measurements were
demonstrated to be useful to evaluate a nutritional inter-
vention. The possibility to include objective measure-
ments related to muscle wasting that are possible to
handle in everyday clinical practice is an advancement in
critical care medicine that should not be underestimated.
The limitation in using computed tomography scans
in clinical practice today is that it involves patient trans-
portation, which may involve medical risks and use of
resources. Another track involving imaging and estima-
tion of skeletal muscle mass, which easily can be
brought to the bedside, is the use of ultrasound. Several
investigators have demonstrated the use of ultrasound to
monitor sarcopenia in critically ill patients over time
[19]. In a recent study, ICU patients were investigated
with repeated ultrasound assessment of leg muscle [20].
A relation between the severity of illness and the extent
of the shrinkage of muscle cross-sectional area was re-
ported. In addition, the report included biochemical data
for protein content and protein kinetics in subgroups of
patients in parallel to the imaging data. Although the re-
port did not include any linking of the imaging by ultra-
sound to the biochemical alterations in skeletal muscle,
which reflects the mechanisms behind the rather aggres-
sive muscle depletion often seen in critical illness, the ef-
fort to present measurements obtainable on an everyday
clinical basis to underlying mechanistic data is a concep-
tual breakthrough.
The recent developments of imaging and tissue signal-
ling should in the near future make it possible to define
changes over time in individual patients and to link this
to clinically relevant correlates. This future is particularly
true for the measures of gene expression and signalling
[21,22]. This link is well demonstrated in critically ill pa-
tients in relation to skeletal muscle degradation [22-24],
which is the major mechanistic component of the
Figure 1 Protein content in skeletal muscle related to DNA.
Protein content in skeletal muscle (ASP – Alkali Soluble Protein)
related to DNA in (A) healthy subjects, (B) preoperative patients
undergoing elective surgery, and (C) critically ill patients (n = 147).
Data assembled from a number of published studies by the authors
as indicated [5,6,8-12].
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seen in gene expression and signalling in skeletal muscle
during critical illness should be linked both to physio-
logical changes in protein kinetics and to clinical rele-
vant data [22,25]. Here the imaging may prove to be
helpful. It seems plausible to predict a development
where individual changes in estimates of muscle massFigure 2 Muscle protein turnover in fed critically ill patients
and healthy volunteers. Muscle protein turnover data from fed
critically ill patients (n = 7) and fed healthy volunteers (n = 8). Both
groups were fed according to energy expenditure. Muscle protein
turnover was measured and calculated using isotopically labelled
phenylalanine (Phe) and employing a two-pool model of the leg.
Bars demonstrate a similar muscle protein synthesis rate, but a
different protein degradation rate (P < 0.05), resulting in a different
protein balance (P < 0.05). Data illustrate the underlying mechanism
behind the rapid development of sarcopenia in critical illness. Data
with permission from [22]. *Statistically different from healthy
controls, P < 0.05.will be sufficiently accurate to be directly linked to the
quantitative measures of underlying mechanisms. The
data presented by Casaer and colleagues indicate this
type of precision when changes in muscle volume were
statistically related to changes in body weight and caloric
intake [18].
Today there are every few studies in which post-ICU
muscle function is evaluated. Interesting pilot studies are
at hand [26], but the limitation is often the difficulty to
recruit a representative sample. There is an evolving lit-
erature over post-ICU quality of life in general, usually
relying upon questionnaires that are well validated
[27,28]. Again, the limitation is most often the difficulty
to recruit representative samples. Nevertheless, aware-
ness of the difficulties involved means that the accuracy
of results is improving over time. Imaging may be help-
ful in bridging the clinical finding during the ICU stay to
functional status post-ICU. The link between sarcopenia
during the ICU stay as a possible reflection of malnutri-
tion and mortality outcome presented by Weijs and col-
leagues is a promising example in this direction [17].
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